Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest S250 Stories

2012-06-11 06:24:26

LITTLETON, Mass., June 11, 2012 /PRNewswire/ -- Mevion Medical Systems, Inc., a radiation therapy company dedicated to advancing the treatment of cancer, announced today that it has received FDA 510(k) clearance for its MEVION S250 Proton Therapy System. The MEVION S250 is a first-of-its-kind proton therapy system that provides the same precise, non-invasive treatment advantages and capabilities of complex, large, and costly proton therapy systems but with higher patient throughput, a...

2012-01-23 09:16:00

WELLINGTON, Fla., Jan. 23, 2012 /PRNewswire/ -- South Florida Radiation Oncology, LLC (SFRO) (www.sfrollc.com) is pleased to announce its agreement with Mevion Medical Systems to purchase the MEVION S250 proton therapy system, (www.mevion.com). SFRO plans to develop the first proton therapy treatment center in West Palm Beach. The first proton therapy system installation is targeted to begin in 2013. South Florida Radiation Oncology is a group of leading radiation oncology...

2011-10-03 07:00:00

LITTLETON, Mass., Oct. 3, 2011 /PRNewswire/ -- Mevion Medical Systems, Inc. announced today that it changed its name from Still River Systems, Inc. This change reflects the company's transition from a research and development organization to the commercial manufacturer of the MEVION S250(TM) Proton Therapy System. Proton therapy is widely regarded as the optimal means of delivering therapeutic radiation to treat a variety of cancers, but is not widely available because of the immense size,...